Cost-effectiveness of broadly neutralizing antibodies for HIV prophylaxis for infants born in settings with high HIV burdens.
Saved in:
| Title: | Cost-effectiveness of broadly neutralizing antibodies for HIV prophylaxis for infants born in settings with high HIV burdens. |
|---|---|
| Authors: | Alba C; Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, Massachusetts, United States of America., Malhotra S; IAVI, New York, New York, United States of America., Horsfall S; Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, Massachusetts, United States of America., Barnhart ME; Office of HIV/AIDS, Bureau for Global Health, Agency for International Development (USAID), Washington, DC, United States of America., Bekker A; Department of Pediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa., Chapman K; IAVI, New York, New York, United States of America., Cunningham CK; Department of Pediatrics, University of California Irvine, Irvine, California, United States of America.; Department of Pediatrics, Children's Hospital of Orange County, Orange, California, United States of America., Fast PE; IAVI, New York, New York, United States of America.; Pediatric Infectious Diseases, Stanford University School of Medicine, Palo Alto, California, United States of America., Fouda GG; Department of Pediatrics, New York-Presbyterian/Weill Cornell Medical Center, New York, New York, United States of America., Freedberg KA; Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, Massachusetts, United States of America.; Harvard Medical School, Boston, Massachusetts, United States of America.; Department of Health Policy and Management, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, United States of America., Goga A; South African Medical Research Council, Cape Town, South Africa.; Department of Paediatrics and Child Health, University of Pretoria, Pretoria, South Africa., Ghazaryan LR; Office of HIV/AIDS, Bureau for Global Health, Agency for International Development (USAID), Washington, DC, United States of America., Leroy V; Centre d'Epidémiologie et de Recherche en santé des POPulations (CERPOP), Inserm and Université Toulouse III, Toulouse, France., Mann C; Office of HIV/AIDS, Bureau for Global Health, Agency for International Development (USAID), Washington, DC, United States of America., McCluskey MM; Office of HIV/AIDS, Bureau for Global Health, Agency for International Development (USAID), Washington, DC, United States of America., McFarland EJ; Department of Pediatrics, Children's Hospital Colorado and University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States of America., Muturi-Kioi V; Eastern Africa Regional Office, IAVI, Nairobi, Kenya., Permar SR; Department of Pediatrics, New York-Presbyterian/Weill Cornell Medical Center, New York, New York, United States of America., Shapiro R; Division of Infectious Diseases, Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States of America., Sok D; IAVI, New York, New York, United States of America.; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, California, United States of America., Stranix-Chibanda L; Child and Adolescent Health Unit, University of Zimbabwe Faculty of Medicine and Health Sciences, Harare, Zimbabwe., Weinstein MC; Department of Health Policy and Management, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, United States of America., Ciaranello AL; Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, Massachusetts, United States of America.; Harvard Medical School, Boston, Massachusetts, United States of America.; Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, United States of America., Dugdale CM; Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, Massachusetts, United States of America.; Harvard Medical School, Boston, Massachusetts, United States of America.; Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, United States of America. |
| Source: | PloS one [PLoS One] 2025 Mar 19; Vol. 20 (3), pp. e0318940. Date of Electronic Publication: 2025 Mar 19 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1932-6203 |
|---|---|
| DOI: | 10.1371/journal.pone.0318940 |
